Atherosclerosis is a complex chronic inflammatory, degenerative and accumulative consequence of the arterial wall to injurious stimuli, which is significantly driven by persistence proliferative response. The pathophysiology of the disease implies its nanoscale nature and therefore necessitates new nano-medicine approaches to combat it. The role of nanotechnology in diagnosing cardiovascular disorders is expanding rapidly.
Clinical Pharmacology & Toxicology Journal received 133 citations as per Google Scholar report